Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
No. Cancer screening is intended to detect cancer or precancerous abnormalities before symptoms develop, but an abnormal screening result generally does not establish a cancer diagnosis. Further evaluation may involve diagnostic imaging, endoscopy, laboratory testing, biopsy, or another procedure depending on the screening test and suspected condition. False-positive and false-negative results can occur, and screening can also lead to overdiagnosis of cancers that would not have caused symptoms or clinical harm during the person’s lifetime.
Carcinogenesis is the biological process through which genetic and other cellular changes contribute to the development of cancer. These changes can arise through errors during cell division, inherited genetic variants, radiation, infectious agents, chemicals, tobacco-related exposures, or other carcinogenic influences. Evidence that an exposure is capable of contributing to carcinogenesis does not by itself establish that it caused a particular person’s cancer, so the tumor type, nature and extent of exposure, biological mechanism, latency, competing factors, and relevant scientific evidence may all be important.
Cancer stage describes the extent of disease at diagnosis using factors that may include tumor size or local extent, lymph-node involvement, and distant metastasis, depending on the cancer type and staging system. Stage can help guide treatment and provide prognostic information. If the cancer later progresses or recurs, those developments are added to the clinical history, but the original stage generally remains the stage assigned at diagnosis. Restaging may sometimes be performed to characterize recurrent or progressive disease without replacing the original stage.
No. A cancer risk factor indicates that an exposure, characteristic, behavior, or condition is associated with an increased probability of developing cancer, but that association does not by itself establish individual causation. A case-specific analysis may also consider the cancer type, amount and duration of exposure when applicable, latency, biological mechanism, competing risk factors, and the strength and applicability of the scientific evidence. In many individual cases, medicine cannot identify one precise reason that the cancer developed.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
Cancers arising in the same organ can have different genetic, protein, or other molecular characteristics. Biomarker testing can help refine tumor classification, provide prognostic information, support diagnosis in selected cancers, monitor disease in some settings, or identify molecular features associated with response to targeted therapy or immunotherapy. The significance of a finding depends on the cancer type, specific biomarker, testing method, specimen quality, and clinical context, and not every detected molecular alteration has established diagnostic or treatment implications.
